...
首页> 外文期刊>Quimica nova >P-GLYCOPROTEIN AND MULTIDRUG RESISTANCE: STRUCTURE-ACTIVITY RELATIONSHIPS OF MODULATORS
【24h】

P-GLYCOPROTEIN AND MULTIDRUG RESISTANCE: STRUCTURE-ACTIVITY RELATIONSHIPS OF MODULATORS

机译:P-糖蛋白和多药耐药性:调节剂的结构-活性关系

获取原文
获取原文并翻译 | 示例

摘要

P-GLYCOPROTEIN AND MULTIDRUG RESISTANCE: STRUCTURE-ACTIVITY RELATIONSHIPS OF MODULATORS. Multidrug resistance, MDR is a major obstacle for cancer chemotherapy. MDR can be reversed by drugs that vary in their chemical structure and main biological activity. Many efforts have been done to overcome MDR based on studies of structure-activity relationships and in this review we summarize some aspects of MDR mediated by P-glycoprotein (P-gp), as the most experimentally and clinically tested form of drug resistance. The most significant MDR mechanisms revealed until now are shortly discussed. Physicochemical and structural properties of MDR modulators, measures of the MDR reversal, and QSAR studies are included.
机译:P-糖蛋白和多药耐药性:调节剂的结构-活性关系。 MDR是多药耐药性,是癌症化疗的主要障碍。 MDR可以通过化学结构和主要生物学活性不同的药物逆转。基于对结构-活性关系的研究,人们为克服MDR做出了许多努力,在本综述中,我们总结了由P-糖蛋白(P-gp)介导的MDR的某些方面,这是药物耐药性最实验和临床测试的形式。简短讨论了迄今为止揭示的最重要的MDR机制。包括MDR调节剂的理化和结构性质,MDR逆转的量度和QSAR研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号